US equities |
MU $877.55 ▲+2.46% NVDA $210.96 ▼-0.59% SPCX $147.49 ▲+1.89% AAPL $347.73 ▼-0.14% TSLA $372.22 ▼-0.63% SNDK $1,238.03 ▼-1.82% META $642.62 ▼-0.96% AMD $516.79 ▲+1.74%
FinancialContent

Articles published by Hims & Hers

< Previous 1 2 Next >
News headline image
Hims Expands Testosterone Care with Injectable and Oral TRT, Its Largest Men’s Health Launch to Date
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers to Announce Third Quarter 2026 Financial Results on November 9, 2026
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Names Jon Franklin as Chief Accounting Officer
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Names Chief Medical Officers in the UK and Australia, Deepening its Investment in Local Clinical Leadership
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims Enters Australia, Marking First Expansion into the Asia-Pacific Market
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Health, Inc. Reports Second Quarter 2026 Financial Results
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Introduces New Hers App with First-of-Its-Kind, Doctor-Led, AI-Native Care Experience
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Responds to FTC Lawsuit
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Completes Acquisition of Eucalyptus, Advancing its Position as the World’s Largest Consumer Health Platform
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Expands Benefits for Active Subscribers With Eight New Health and Wellness Partners
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Expands GLP-1 Offering in Canada with Generic Semaglutide
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Health, Inc. Prices Upsized $350 Million Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Health, Inc. Reports First Quarter 2026 Financial Results
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Nominates Kofi Amoo-Gottfried to its Board of Directors
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers to Announce First Quarter 2026 Financial Results on May 11, 2026
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Novo Nordisk’s FDA-Approved GLP-1s Now Available With Hims & Hers
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Names Kathryn Beiser as Chief Communications Officer
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Introducing Hims & Hers Benefits, Unlocking Health & Wellness Discounts for Subscribers
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Announces Strategic Shift for US Weight Loss Business
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Announces Agreement to Acquire Eucalyptus, Accelerating Its Vision to Become the Leading Global Consumer Health Platform
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Expands Personalized Weight Loss Portfolio with Access to Compounded Semaglutide Pills Starting at $49/Month*
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Launches Multi-Cancer Early Detection Testing, Connecting Customers to Cutting-Edge Proactive Care
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers to Announce Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Returns to the Big Game with a Message to All Americans: The Era of Health as a Luxury is Over
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Brings Comprehensive Weight Loss Programme to the UK
From Hims & Hers
Via Business Wire
Tickers HIMS
< Previous 1 2 Next >